In what's shaping into a healthcare showdown, Legacy Health is threatening to sever ties with Regence BlueCross BlueShield come March end if the insurance giant doesn't loosen its purse strings. Should the contract expire without a new one in place, thousands of Oregonians could find their wallets in a pinch when seeking care at Legacy facilities.
Legacy, a major player in Oregon's medical scene with seven hospitals and a substantial clinic network, has publicly decried Regence's current reimbursement rates, which they claim haven't kept up with the roaring tide of inflation and ballooning labor costs that have surged post-pandemic, according to a statement obtained by KGW. Legacy argues that to continue providing care, particularly with a potential double-digit hike in costs, it needs more backing from its insurers.
The spat echoes a previous wrangle between Providence Health & Services and Regence in Oregon, proving this is no isolated incident but part of a wider, unnerving trend in healthcare negotiations. Merrin Permut, Legacy's vice president and chief population health officer, stated, "We’re asking Regence to support an increase that reflects the economic realities in healthcare today", as reported by Portland Business Journal. This dispute comes as Legacy announces its intention to be acquired by OHSU, potentially increasing its leverage.
Regence has retorted, lamenting the public airing of the dispute, which they say "puts patients in the middle and causes unnecessary stress". The insurer stands firm against what it calls a "double-digit price increase" with a warning that such demands could destabilize the financial equilibrium critical to meeting medical claims, according to the statement provided by OPB. With Legacy pulling in 200,000 Regence-insured patients in 2022 and having lost $172 million in fiscal year 2023, there's a lot on the line.
The clock is ticking as the March 31 deadline looms. For now, Legacy's stance is clear, but whether Regence will bend before the ultimate face-off remains to be seen. Concerned policyholders must wait with bated breath as negotiations continue, hoping that this corporate game of chicken doesn't end with their health options clipped.
